| Stacy Aileen Meulenaere, OTR/L | |
|
281 Lincoln St, Worcester, MA 01605-2138 | |
| (508) 334-1000 | |
| Not Available |
| Full Name | Stacy Aileen Meulenaere |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 281 Lincoln St, Worcester, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003096660 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 8846 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stacy Aileen Meulenaere, OTR/L 281 Lincoln St, Worcester, MA 01605-2138 Ph: () - | Stacy Aileen Meulenaere, OTR/L 281 Lincoln St, Worcester, MA 01605-2138 Ph: (508) 334-1000 |
News Archive
Research by investigators at The Cancer Institute of New Jersey (CINJ) is showing new promise in the treatment of melanoma, the most serious of skin cancers. The findings, published in the May 27, 2010, online edition of the Journal of Investigative Dermatology further validate the team's clinical and pre-clinical findings that blocking the signaling normally activated by a receptor called Grm1 results in decreased cell growth and decreased migration of melanoma cells, confirming that Grm1 is a potential target for the treatment of melanoma.
Researchers at the University of Illinois at Urbana-Champaign have figured out how to reverse the characteristics of a key bonding material-polyurea-providing an inexpensive alternative for a broad number of applications, such as drug delivery, tissue engineering, and packaging.
"After a century of progress, the issues that medicine must tackle in the coming year aren't that different from the ones that faced doctors at the start of 1911, according to the observations" published Jan. 1 in a Lancet editorial, LiveScience reports (Parry, 12/30).
AVEO Oncology today announced that data from a planned interim analysis of the Phase 2 BATON (Biomarker Assessment of Tivozanib in ONcology) study in patients with colorectal cancer (CRC) indicate that the study is unlikely to meet the primary endpoint in the intent-to-treat patient population.
› Verified 9 days ago
Cara Rose Mclaughlin, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 484 Main St, Worcester, MA 01608 Phone: 800-244-2756 Fax: 508-831-9768 | |
Mrs. Elsa Grace Horne-naylor, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 484 Main St, Worcester, MA 01608 Phone: 800-244-2756 Fax: 508-831-9768 | |
Lauren Marie Murray, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 378 Plantation St, Worcester, MA 01605 Phone: 508-755-9731 | |
Lucy Clarke, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 18 Chestnut St, Worcester, MA 01608 Phone: 800-244-2756 | |
Ms. Lisa Caramanica, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 55 Lake Ave N, Occupational Therapy, Worcester, MA 01655 Phone: 508-334-8700 | |
Cassandra Bolles, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 484 Main St, Worcester, MA 01608 Phone: 800-244-2756 |